-
Something wrong with this record ?
Aspergillus fumigatus DBM 4057 biofilm formation is inhibited by chitosan, in contrast to baicalein and rhamnolipid
E. Kvasničková, V. Paulíček, M. Paldrychová, R. Ježdík, O. Maťátková, J. Masák,
Language English Country Germany
Document type Journal Article
NLK
ProQuest Central
from 1997-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 1997-01-01 to 1 year ago
- MeSH
- Amphotericin B pharmacology MeSH
- Antifungal Agents pharmacology MeSH
- Aspergillus fumigatus drug effects physiology MeSH
- Biofilms drug effects MeSH
- Chitosan pharmacology MeSH
- Flavanones pharmacology MeSH
- Glycolipids pharmacology MeSH
- Microbial Sensitivity Tests MeSH
- Publication type
- Journal Article MeSH
The biofilms of filamentous-forming fungi are a novel and still insufficiently understood research topic. We have studied Aspergillus fumigatus, an ubiquitous opportunistic pathogenic fungus, as a representative model for a study of biofilm formation by filamentous fungi and for assessing the potential anti-biofilm activity of natural substances. The activity of antibiotic amphotericin B and selected natural substances: baicalein, chitosan and rhamnolipid was studied. The minimum suspension inhibitory concentrations (MIC) were determined and the biofilm susceptibility was investigated by determining the metabolic activity of sessile cells (XTT assay) and total biofilm biomass (crystal violet staining). Significant time-dependent differences in substances' anti-biofilm activity were observed. Images of A. fumigatus biofilm were obtained by Cellavista automatic light microscope and spinning disc confocal microscopy. Baicalein and rhamnolipid were not found as suitable substances for inhibition of the A. fumigatus biofilm formation, as neither of the substances inhibited the sessile cells metabolic activity or the total biofilm biomass even at tenfold MIC after 48 h. In contrast, chitosan at 10 × MIC (25 µg mL(-1)), suppressed the biofilm metabolic activity by 90 % and the total biofilm biomass by 80 % even after 72 h of cultivation. Amphotericin B inhibited only 14 % of total biofilm biomass (crystal violet staining) and 35 % of metabolic activity (XTT assay) of adherent cells under the same conditions. Our results therefore suggest chitosan as potential alternative for treating A. fumigatus biofilm-associated infections.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17013512
- 003
- CZ-PrNML
- 005
- 20170425095140.0
- 007
- ta
- 008
- 170413s2016 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s11274-016-2146-9 $2 doi
- 035 __
- $a (PubMed)27660214
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Kvasničková, Eva $u Department of Biotechnology, University of Chemistry and Technology, Prague, Technická 5, 166 28, Prague 6, Czech Republic.
- 245 10
- $a Aspergillus fumigatus DBM 4057 biofilm formation is inhibited by chitosan, in contrast to baicalein and rhamnolipid / $c E. Kvasničková, V. Paulíček, M. Paldrychová, R. Ježdík, O. Maťátková, J. Masák,
- 520 9_
- $a The biofilms of filamentous-forming fungi are a novel and still insufficiently understood research topic. We have studied Aspergillus fumigatus, an ubiquitous opportunistic pathogenic fungus, as a representative model for a study of biofilm formation by filamentous fungi and for assessing the potential anti-biofilm activity of natural substances. The activity of antibiotic amphotericin B and selected natural substances: baicalein, chitosan and rhamnolipid was studied. The minimum suspension inhibitory concentrations (MIC) were determined and the biofilm susceptibility was investigated by determining the metabolic activity of sessile cells (XTT assay) and total biofilm biomass (crystal violet staining). Significant time-dependent differences in substances' anti-biofilm activity were observed. Images of A. fumigatus biofilm were obtained by Cellavista automatic light microscope and spinning disc confocal microscopy. Baicalein and rhamnolipid were not found as suitable substances for inhibition of the A. fumigatus biofilm formation, as neither of the substances inhibited the sessile cells metabolic activity or the total biofilm biomass even at tenfold MIC after 48 h. In contrast, chitosan at 10 × MIC (25 µg mL(-1)), suppressed the biofilm metabolic activity by 90 % and the total biofilm biomass by 80 % even after 72 h of cultivation. Amphotericin B inhibited only 14 % of total biofilm biomass (crystal violet staining) and 35 % of metabolic activity (XTT assay) of adherent cells under the same conditions. Our results therefore suggest chitosan as potential alternative for treating A. fumigatus biofilm-associated infections.
- 650 _2
- $a amfotericin B $x farmakologie $7 D000666
- 650 _2
- $a antifungální látky $x farmakologie $7 D000935
- 650 _2
- $a Aspergillus fumigatus $x účinky léků $x fyziologie $7 D001232
- 650 _2
- $a biofilmy $x účinky léků $7 D018441
- 650 _2
- $a chitosan $x farmakologie $7 D048271
- 650 _2
- $a flavanony $x farmakologie $7 D044950
- 650 _2
- $a glykolipidy $x farmakologie $7 D006017
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Paulíček, Vít $u Department of Biotechnology, University of Chemistry and Technology, Prague, Technická 5, 166 28, Prague 6, Czech Republic.
- 700 1_
- $a Paldrychová, Martina $u Department of Biotechnology, University of Chemistry and Technology, Prague, Technická 5, 166 28, Prague 6, Czech Republic.
- 700 1_
- $a Ježdík, Richard $u Department of Biotechnology, University of Chemistry and Technology, Prague, Technická 5, 166 28, Prague 6, Czech Republic.
- 700 1_
- $a Maťátková, Olga $u Department of Biotechnology, University of Chemistry and Technology, Prague, Technická 5, 166 28, Prague 6, Czech Republic. olga.matatkova@vscht.cz.
- 700 1_
- $a Masák, Jan $u Department of Biotechnology, University of Chemistry and Technology, Prague, Technická 5, 166 28, Prague 6, Czech Republic.
- 773 0_
- $w MED00006402 $t World journal of microbiology & biotechnology $x 1573-0972 $g Roč. 32, č. 11 (2016), s. 187
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27660214 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20170425095457 $b ABA008
- 999 __
- $a ok $b bmc $g 1199977 $s 974290
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 32 $c 11 $d 187 $e 20160922 $i 1573-0972 $m World journal of microbiology & biotechnology incorporating the MIRCEN Journal of applied microbiology and biotechnology $n World j. microbiol. biotechnol. $x MED00006402
- LZP __
- $a Pubmed-20170413